Abivax S.A. (ABVX) stock
ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
$87.58−2.62 (-2.90%)
Close on Nov 13, 2026Market cap $6.88BP/E –Yield –
Abivax pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Abivax
Abivax has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?